Cessatech A/S Stock

Stocks

End-of-day quote NORDIC GROWTH MARKET 30/09/2026			5-day change	1st Jan Change
9.300 ^DKK	+1.53%		-.--%	-41.73%

10-30	Cessatech receives positive feedback in contacts with around 50 hospitals, aims to provide clearer outlook for 2027	FW
08-28	Cessatech A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

NORDIC GROWTH MARKETDKK

10-30	Cessatech receives positive feedback in contacts with around 50 hospitals, aims to provide clearer outlook for 2027	FW
08-28	Cessatech A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-28	Cessatech reports a slightly smaller operating loss	FW
08-28	Cessatech partner has released the first commercial batch of CT001 in the US	FW
08-28	Cessatech Releases CT001 For Shipment To Initial U.S. Hospitals And Commences Launch Activities	CI
07-24	CHMP says no to KemSu, review requested	FW
06-12	Cessatech partners with Rigshospitalet for CT004 development	FW
06-12	Cessatech A/S and University Hospital of Copenhagen, Rigshospitalet Enter Collaboration to Advance Intravenous Formulation of Melatonin for Post-Anaesthesia Delirium in Children	CI
05-28	Cessatech narrows losses	FW
05-28	Cessatech A/S Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-27	Cessatech A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
02-27	Cessatech's Operating Loss Decreased in 2025	FW
02-27	Cessatech A/S Auditor Raises 'Going Concern' Doubt	CI

08-28	Second Quarter Report Q2-2026	AQ
08-28	CT001 ready for shipment to initial U.S. hospitals as launch activities commence	AQ
08-03	Cessatech: Cessatech – EMA initial KemSu/CT001 opinion Q&A and next steps	PU
08-03	Cessatech - EMA initial KemSu/CT001 opinion Q&A and next steps	AQ
07-24	Cessatech: Proveca intends to request a re-examination of CHMP opinion for CT001/KemSu	PU

Manager	Title	Age	Since
Jes Trygved CEO	Chief Executive Officer	53	01/01/2020
Sarah Margaux Toft-Jørgensen DFI	Director of Finance/CFO	-	01/11/2025
Martin Juhl CTO	Chief Tech/Sci/R&D Officer	-	01/03/2022

Director	Title	Age	Since
Martin Olin CHM	Chairman	57	01/01/2022
Flemming Steen Jensen BRD	Director/Board Member	65	01/01/2020
Charlotte Videbaek BRD	Director/Board Member	64	01/01/2020

Employees

Sector